Journal Home
Search for


MANUSCRIPT PREPARATION & SUBMISSION

Authors are invited to submit manuscripts for review, in English, relating to any aspect of Wound Care. The JACCWS is interested in the publication of manuscripts spanning the entire spectrum of wound care: clinical, basic, and translational science, from any relevant perspective. A clear indication of clinical relevance is essential for publication. Manuscript categories for submission include but are not limited to: Scientific/Clinical papers, Case-Reports, Case Studies, Literature Review, Review of Current Wound Care Issue Review of New Procedures, Review of New Products, Interviews with Wound Care Specialists, Relevant Clinical News Inquiries for the Editor-in-Chief should be made to: Dr. Richard Simman's email: plasticsimman@yahoo.com

MANUSCRIPT CATEGORIES

Scientific/Clinical Research Report: A full-length report of an original basic, applied, or clinical research investigation that advances the clinical science of wound care.

Systematic reviews and randomized clinical trials of different interventions, performed prospectively with adequate controls, are typical of the reports in this category.

Case Report: A detailed description of the management of a unique clinical case problem. The description of the case includes but not limoted to the relevant patient characteristics, examination/ evaluation, diagnosis, and a description of the interventions that were provided.

Case series describing the management of a small group of similar patients, with no comparison group, also fit this category.

Literature Review: A comprehensive review of the literature, addressing a topic of interest and relevance to wound care. Reviews of literature may take the form of a traditional review, or a metaanalysis. The Editor-in-Chief may invite manuscripts submitted in this category. Selfnominations for an invitation to submit a literature review may be sent via email be to the Editorin- Chief, and should include a cover letter and current curriculum vitae.

Review of Current Wound Care Issue Review of New Procedures, Review of New Products: These reviews must address a topic of interest and relevance to wound care. Interviews with Wound Care Specialists: The editor- in-chief will review all submitted interviews. However, this category is generally reserved for invited interviewers.

Letters to the Editor: All letters and/or relevant comments regarding the content of the JACCWS Therapy must be submitted by email to:letters.jaccws@gmail.com.

BOOK REVIEWS

Book reviews are accepted after invitation from the Assistant Editor. Potential reviewers may contact the Assistant editor by email to: jaccwseditors@gmail.com.

Submission of Manuscripts: All new manuscripts must be submitted through the JACCWS online submission and review Web site (External link http://ees.elsevier.com/jaccws/ ).

Reviews are requested to submit the text, tables, and artwork in electronic form (text should be formatted in MS Word, not as a PDF).

Submission items include a cover letter (save as a separate Word file for upload), a title page (because we employ a double-blinded review process you will be asked to save the title page as a separate file for upload), the manuscript, (without the title page) formatted with a font size no smaller than 11 point and with 1-inch margins and indented paragraphs. The manuscript should include the abstract, main text, references, and figure legends. Revised manuscripts should also be accompanied by a unique file (separate from the cover letter) with responses to the reviewers' comments. Authors must follow the guidelines of the EES submission process. Please contact the editors for any questions regarding the submission process.

COVER LETTER

In an accompanying cover letter to the Editor-in Chief, authors should state that any manuscript, or parts of it, have not been and will not be submitted elsewhere for publication.

The name of the Institutional Review Board that approved the research protocol involving human subjects must also be included in the cover letter (the methods section must also contain a statement that informed consent was obtained and that the rights of the human subjects were protected). For a description of ethical principles for medical research involving human subjects see the "World Medical Association Declaration of Helsinki policy" www.wma.net/e/policy/b3.htm.

Case Reports, when applicable, should include a statement that each subject was informed that data concerning the case would be submitted for publication or a statement indicating approval by an appropriate review board.

Patient confidentiality must be protected. Any use of experimental animals in submitted research papers must include a statement that an animal utilization study committee approved the study. Manuscripts with experimental results on cadavers must include a statement that a relevant utilization study committee approved the study. Finally, the cover letter should include a statement concerning any potential conflicts of interest and/ or a financial disclosure of any support received.

TITLE PAGE

Because we employ a double-blind review process, please save the title page as a separate file (it will not be built into any documents seen by reviewers). The title page should contain the title of the article, the authors' names, their academic degrees, and their present affiliations.

The name of the corresponding author should be given with a reliable mailing address, telephone number, and fax number. Authors should indicate whether the paper was adapted from a presentation at a meeting and should acknowledge any grant support related to the paper. Disclaimers: if there are no disclaimers, please enter "none".

MANUSCRIPT and ABSTRACT

All manuscripts should include the abstract (suggested 150 word limit), main text, references, and figure legends. All authors should consult the uniform requirements for manuscripts submitted to biomedical journals: "Writing and Editing for Biomedical Publication" (www.icmje.org/icmje.pdf). Due to the doubleblind review process the manuscript should not carry any author, facility, or institution identifiers.

Authors should use the following terminology when naming their study design. We recognize that this list is not all-inclusive and that more appropriate descriptors might be suitable for some studies. Authors are encouraged to pick the most appropriate study design descriptors for their study. These suggestions are merely provided as a means of encouraging consistency where it would be both useful and informative.

Quantitative Study design options (for treatment effectiveness and prognosis types of research - may also apply to diagnosis study.

1. Systematic review: a synthesis of the better quality quantitative studies

2. Randomized Clinical Trial: patients are enrolled at a relevant baseline and allocated to different intervention arms based on a random concealed process; outcomes are ascertained prospectively

3. Prospective Cohort: a longitudinal study where subgroups of patients are enrolled and research questions defined at a relevant baseline point (prior to when outcomes occur); patients are followed forward in time for outcomes ascertainment. For treatment studies at least 2 groups are defined at baseline; in prognostic studies potential predictors are collected at baseline

4. Retrospective Cohort: a longitudinal study where subgroups of patients are involved in a prospective data collection but the research questions (and variables) were defined retrospectively; treatment groups or prognostic factors may have been defined after data collections was initiated e.g. database research

5. Case-Control: a longitudinal study where subgroups of patients are identified/enrolled after outcomes have been ascertained and data are collected retrospectively (recall or pre-exising data) on the treatment or prognostic factors of interest

6. N-of-1: Asingle patient is enrolled at a relevant baseline andallocated to cross-over different intervention arms based on a random concealed process; outcomes are ascertained prospectively

7. Case Series*: Data are collected on a single subgroup of patients (no comparison group)

8. Case Report: Data are collected on a single subject

Other Quantitative Study Designs

1. Clinical measurement*: eg, reliability, validity, responsiveness, clinimetric, psychometric, utility, etc

2. Descriptive*: Includes surveys, other descriptive data collection

3. Economic Analysis

4. Consensus statements: Systematic processes used to define or develop consensus on clinical topics

5. Bench (experimental laboratory based) research*: biomechanics, electromyography, physiology* may be sub-grouped as

a. Longitudinal: data were collected at multiple time points

b. Cross-sectional: data were collected on a single occasion

Qualitative Study Designs

1. Meta-syntheses: a synthesis of the better quality qualitative studies

2. Grounded Theory: research that seeks to understand and identify theoretical processes; themes used to develop an understanding and theoretical explanation

3. Case Study: an in-depth study of an individual lived experience and perspective Authors will need to determine the level of evidence for all eligible studies. The Oxford Centre for Evidence- based Medicine website at www.cebm.-net/levels_of_evidence.asp provides guidelines as to determining the level of evidence.We recognize that not all forms of studies can be classified. For example, these criteria do not apply to practice forum, practice guidelines, clinical measurement, lab or qualitative studies.

TABLES

Save each table, double spaced, as a separate file for upload. It must include a table number and a title. Each table should first be cited in numerical order in the text

PHOTOGRAPHS/ILLUSTRATIONS

Save illustrations as separate files, logically named (e.g., Fig1.tif, Fig2.eps). When submitting the illustrations, please use either JPEG, an EPS or TIF format. Graphics software such as Photoshop and Illustrator, not presentation software such as PowerPoint, CorelDraw, or Harvard Graphics, must be used to create art. Color images need to be saved as CMYK, at least 300 dots per inch (dpi). Grayscale images should be at least 300 dpi. Line art (black and white or color) should be at least 1,000 dpi, and combinations of grayscale and line art should be at least 600 dpi. Please note that once you create digital art at low resolution, you cannot adjust it. You must create your art at the proper resolution (dpi) to begin with. For step-by-step instruction and screenshots on how to create your art correctly the first time, please click on the "Artwork Guidelines" link in the Author Information box on our submission site homepage or go to Elsevier's Author Gateway (External link http://authors.elsevier.com) and click on "Artwork instructions" and then select "Application Guidelines."

REFERENCES

Each reference in the text must be indicated by number, and the references as first cited in text must be in numerical order. The Index Medicus style for journal abbreviations should be used, and references should be based on American Medical Association Manual of Style, 9th ed., 1998. See site examples at External link http://healthlinks.washington.edu/hsl/styleguides/ama.html .

PERMISSIONS

Borrowed material must be accompanied by written permissions from the publisher and from the corresponding author of the book or journal article in which the material originally appeared. Signed releases must accompany photographs of identifiable living persons. Please indicate that you have secured these rights in your cover letter.

CONFLICT-OF-INTEREST POLICY

A conflict-of-interest statement will be required for each manuscript accepted for publication. This statement will have no bearing on the editorial decision to publish a manuscript. That decision will be based solely on the value of the article to the readers of the Journal.

AUTHOR INQUIRIES

For Inquiries relating to the submission of articles, please visit www.elsevier.com/authors. This site also provides the facility to track accepted articles and set up e-mail alerts to inform you of when an article's status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions, and more.



Updated March 2010